Uveitis Specialists, Rheumatologists Differ in Anterior Scleritits Tx Decisions

The researchers surveyed 1044 uveitis specialists and rheumatologists
The researchers surveyed 1044 uveitis specialists and rheumatologists

Uveitis specialists and rheumatologists differ significantly in their most-selected first-choice treatment option for patients with anterior scleritis, according to new findings from a survey by researchers at the University of Colorado.

The researchers surveyed 1044 uveitis specialists and rheumatologists; a total of 92 responding (8.6%). Those respondents answered questions on first and second choice therapies, and re-select therapies, assuming that the costs of all options were equal and that insurance approval was ensured. 

Related Articles

Methotrexate was the most selected first-choice treatment for 78.6% of rheumatologists, compared with 44.4% of uveitis specialists (P<0.009). Mycophenolate was the most selected first-choice treatment for 27.8% of uveitis specialist and just 5.3% of rheumatologists (P<0.015).

The authors noted that controlled trial data is lacking in management guidance for anterior scleritis. They concluded that treatment preferences are impacted more by specialty than by cost/insurance.

For more information visit Springer.com.

Loading links....